CN104193767A - Cefamandole nafate superfine powder preparation and preparation method thereof - Google Patents
Cefamandole nafate superfine powder preparation and preparation method thereof Download PDFInfo
- Publication number
- CN104193767A CN104193767A CN201410385066.7A CN201410385066A CN104193767A CN 104193767 A CN104193767 A CN 104193767A CN 201410385066 A CN201410385066 A CN 201410385066A CN 104193767 A CN104193767 A CN 104193767A
- Authority
- CN
- China
- Prior art keywords
- sodium
- preparation
- superfine powder
- compound
- formylcefamole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000000843 powder Substances 0.000 title claims abstract description 23
- 229960002440 cefamandole nafate Drugs 0.000 title abstract 3
- RRJHESVQVSRQEX-SUYBPPKGSA-N O-formylcefamandole Chemical compound CN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)[C@H](OC=O)C=3C=CC=CC=3)[C@H]2SC1 RRJHESVQVSRQEX-SUYBPPKGSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims abstract description 16
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 14
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 7
- HXUIDZOMTRMIOE-UHFFFAOYSA-N 3-oxo-3-phenylpropionic acid Chemical compound OC(=O)CC(=O)C1=CC=CC=C1 HXUIDZOMTRMIOE-UHFFFAOYSA-N 0.000 claims abstract description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000019253 formic acid Nutrition 0.000 claims abstract description 4
- 239000002245 particle Substances 0.000 claims abstract description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 4
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 4
- 159000000000 sodium salts Chemical class 0.000 claims abstract description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 27
- 239000011734 sodium Substances 0.000 claims description 27
- 229910052708 sodium Inorganic materials 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- ICZOIXFFVKYXOM-YCLOEFEOSA-M cefamandole nafate Chemical compound [Na+].CN1N=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)[C@H](OC=O)C=3C=CC=CC=3)[C@H]2SC1 ICZOIXFFVKYXOM-YCLOEFEOSA-M 0.000 claims description 9
- AYDQIZKZTQHYIY-UHFFFAOYSA-N OC(=O)C1(C)CC(C(O)=O)=CC=C1 Chemical compound OC(=O)C1(C)CC(C(O)=O)=CC=C1 AYDQIZKZTQHYIY-UHFFFAOYSA-N 0.000 claims description 6
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000012046 mixed solvent Substances 0.000 claims description 5
- 230000032050 esterification Effects 0.000 claims description 4
- 238000005886 esterification reaction Methods 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical group Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 238000010923 batch production Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- XUTQHTOXGKVJPN-XCGJVMPOSA-N (6r)-7-amino-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound CN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)C(N)[C@H]2SC1 XUTQHTOXGKVJPN-XCGJVMPOSA-N 0.000 abstract 1
- -1 compound cefamandole nafate Chemical class 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LSBDFXRDZJMBSC-UHFFFAOYSA-N Amide-Phenylacetic acid Natural products NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410385066.7A CN104193767B (en) | 2014-08-07 | 2014-08-07 | A kind of cefamandole nafate superfine powder preparation and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410385066.7A CN104193767B (en) | 2014-08-07 | 2014-08-07 | A kind of cefamandole nafate superfine powder preparation and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104193767A true CN104193767A (en) | 2014-12-10 |
CN104193767B CN104193767B (en) | 2016-07-06 |
Family
ID=52079167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410385066.7A Active CN104193767B (en) | 2014-08-07 | 2014-08-07 | A kind of cefamandole nafate superfine powder preparation and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104193767B (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3641021A (en) * | 1969-04-18 | 1972-02-08 | Lilly Co Eli | 3 7-(ring-substituted) cephalosporin compounds |
US3928334A (en) * | 1974-06-06 | 1975-12-23 | Bristol Myers Co | Process for the production of cefamandole |
JPS5390285A (en) * | 1977-01-17 | 1978-08-08 | Sankyo Co Ltd | Preparation of cephalosporin derivs. |
EP0029202B1 (en) * | 1979-11-16 | 1983-04-13 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel tetrazole-5-thiol esters and process for preparing cefamandole using same |
CN101108856A (en) * | 2007-07-27 | 2008-01-23 | 苏州中联化学制药有限公司 | Method for synthesizing antibiotic cefamandole nafate |
CN101475580A (en) * | 2009-01-21 | 2009-07-08 | 海南美大制药有限公司 | Cefamandole nafate compounds and synthesizing method thereof |
CN102276629A (en) * | 2011-08-22 | 2011-12-14 | 苏州二叶制药有限公司 | Synthetic route for cefamandole nanfate |
CN102372728A (en) * | 2011-11-28 | 2012-03-14 | 齐鲁安替制药有限公司 | Synthesizing method for cephalosporin compound |
CN102816172A (en) * | 2012-08-17 | 2012-12-12 | 苏州中联化学制药有限公司 | Preparation process of cefamandole nafate |
WO2013057197A1 (en) * | 2011-10-20 | 2013-04-25 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Process for the formylation of cefamandole |
WO2013057196A1 (en) * | 2011-10-20 | 2013-04-25 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Process for the preparation of cefamandole nafate |
-
2014
- 2014-08-07 CN CN201410385066.7A patent/CN104193767B/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3641021A (en) * | 1969-04-18 | 1972-02-08 | Lilly Co Eli | 3 7-(ring-substituted) cephalosporin compounds |
US3928334A (en) * | 1974-06-06 | 1975-12-23 | Bristol Myers Co | Process for the production of cefamandole |
JPS5390285A (en) * | 1977-01-17 | 1978-08-08 | Sankyo Co Ltd | Preparation of cephalosporin derivs. |
EP0029202B1 (en) * | 1979-11-16 | 1983-04-13 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel tetrazole-5-thiol esters and process for preparing cefamandole using same |
CN101108856A (en) * | 2007-07-27 | 2008-01-23 | 苏州中联化学制药有限公司 | Method for synthesizing antibiotic cefamandole nafate |
CN101475580A (en) * | 2009-01-21 | 2009-07-08 | 海南美大制药有限公司 | Cefamandole nafate compounds and synthesizing method thereof |
CN102276629A (en) * | 2011-08-22 | 2011-12-14 | 苏州二叶制药有限公司 | Synthetic route for cefamandole nanfate |
WO2013057197A1 (en) * | 2011-10-20 | 2013-04-25 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Process for the formylation of cefamandole |
WO2013057196A1 (en) * | 2011-10-20 | 2013-04-25 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Process for the preparation of cefamandole nafate |
CN102372728A (en) * | 2011-11-28 | 2012-03-14 | 齐鲁安替制药有限公司 | Synthesizing method for cephalosporin compound |
CN102816172A (en) * | 2012-08-17 | 2012-12-12 | 苏州中联化学制药有限公司 | Preparation process of cefamandole nafate |
Non-Patent Citations (3)
Title |
---|
CLAUDIO FUGANTI,ET AL.,: "Penicillin acylase mediated synthesis of formyl cefamandole", 《BIOTECHNOLOGY LETTERS》 * |
刘家健: "头孢菌素类品种研发与生产现状探讨", 《中国抗生素杂志》 * |
张文生,等,: "头孢孟多酯钠的合成", 《河北化工》 * |
Also Published As
Publication number | Publication date |
---|---|
CN104193767B (en) | 2016-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101584671B (en) | Cefazedone sodium medicament powder injection and method for synthesizing raw medicine of Cefazedone sodium | |
CN102268019A (en) | Cefadroxil compound and preparation method thereof | |
CN101475580B (en) | Cefamandole nafate compounds synthesizing method | |
CN103396416B (en) | Preparation method of moxifloxacin impurity F | |
CN102924311B (en) | L-ornithine-L-aspartate preparation method | |
CN108047148A (en) | A kind of preparation method of the western Nader's impurity of thunder | |
CN105820145B (en) | A kind of preparation method of 5- nitryl furfural and Nifuratel | |
CN104844625A (en) | Cefamandole nafate new crystal form and crystallization preparing method thereof | |
CN103145636B (en) | 1,4-diacyl-3,6-diphenyl-1,4-dihydrotetrazine compound as well as preparation method and application thereof | |
CN102321100B (en) | Preparation method of cefminox sodium | |
CN107445867A (en) | A kind of synthetic method of KWD-2183 impurity B | |
CN104193767B (en) | A kind of cefamandole nafate superfine powder preparation and preparation method thereof | |
CN111039999A (en) | Synthesis method of etimicin impurity | |
CN102702230B (en) | Method for preparing cefotaxime acid | |
CN102718676B (en) | Agomelatine sulfate and preparation method thereof | |
CN102391259A (en) | Nifuratel compound and preparation method thereof | |
CN104829631A (en) | New crystal form of cefamandole nafate and crystallization and preparation methods thereof | |
CN102391326B (en) | Clindamycin palmitate hydrochloridum compound and preparation method thereof | |
CN104803998B (en) | A kind of method for reducing impurity content | |
CN104402758A (en) | Preparation method of iohexol impurity | |
CN113372362A (en) | Synthesis method of cefalonium impurity B | |
CN102911186A (en) | Ceftizoxime sodium preparation and refining method | |
CN106432279A (en) | Method for preparing medicine ceftriaxone sodium crystal compound for treating surgical infection | |
CN107266442A (en) | The preparation method of piperidines with antitumor activity and pyridine compounds and their | |
CN106432278A (en) | Crystalline compound of drug ceftriaxone sodium for treating surgical operation infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Fu Miaoqing Inventor after: Li Fengsheng Inventor after: Chen Yudong Inventor before: Fu Miaoqing Inventor before: Li Fengsheng Inventor before: Chen Zongdong |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200409 Address after: 310000 room 1301 and 1401, building B, No. 3, Weiye Road, Binjiang District, Hangzhou City, Zhejiang Province Patentee after: ZHEJIANG CHANGDIAN PHARMACEUTICAL Co.,Ltd. Address before: Room 701, building 2, Tongce Plaza, 3688 Jiangnan Avenue, Binjiang District, Hangzhou City, Zhejiang Province Patentee before: HANGZHOU CHANGDIAN MEDICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to an ultra-fine powder preparation of cefmendole axetil sodium and a preparation method thereof Effective date of registration: 20210325 Granted publication date: 20160706 Pledgee: China Minsheng Banking Corp Hangzhou branch Pledgor: ZHEJIANG CHANGDIAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021330000241 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20160706 Pledgee: China Minsheng Banking Corp Hangzhou branch Pledgor: ZHEJIANG CHANGDIAN PHARMACEUTICAL CO.,LTD. Registration number: Y2021330000241 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |